Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
mRNA
Sort By
Newest First
1 / 5
RNA
Is mRNA a Gene Therapy? Unpacking the Evolving Regulatory Debate
Cynthia A. Challener, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
PAO-03-25-NI-06
Mar 26, 2025
RNA
What new opportunities are emerging for mRNA technology, and how is the portfolio of applications expanding beyond vaccines?
Pharma's Almanac
PAO-03-25-RT-02
Mar 26, 2025
RNA
Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-24
Mar 21, 2025
xRNA
Revolutionizing xRNA Production: The Economic Case for Continuous Manufacturing
Aaron B. Cowley, Ph.D.
ReciBioPharm
PAO-02-25-CL-11
Feb 13, 2025
RNA
Enabling Cost-Effective, Rapid Access to RNA Vaccines and Therapeutics with Enzymatically Generated z- dbDNA
Lisa Caproni
Touchlight
PAO-01-25-CL-08
Feb 10, 2025
Advanced Therapies
Ensuring Nuclease Free Process Consumables for Biopharma Applications
Richard Fry
Sanisure
PAO-01-25-CL-05
Jan 22, 2025
Sustainability
Synthetic DNA Delivers a Sustainable Future for Genetic Medicines
Touchlight
PAO-01-25-CL-04
Jan 07, 2025
RNA
Screening T7 Polymerases to Optimize xRNA Yield and Quality
Jing Zhu, Ph.D.
ReciBioPharm
PAO-01-25-CL-02
Jan 07, 2025
RNA
Lexogen launches Streamlined, Large-scale RNA-Seq Service for Blood Samples
Lexogen
PR-11-24-NI-99
Nov 15, 2024
Biomanufacturing
Transforming xRNA Manufacturing with Digital Technologies and Continuous Processing
Aaron B. Cowley, Ph.D.
ReciBioPharm
PAO-11-24-CL-04
Nov 11, 2024
Advanced Therapies
A New Vision for Progressing Advanced Therapies
Nathaniel Youndt
ReciBioPharm
PAO-10-24-CL-13
Oct 25, 2024
Large Molecule
Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis
Waters Corporation
PR-10-24-NI-38
Oct 11, 2024
RNA
Optimized Residual dsRNA Detection for mRNA Therapeutics
Eunseo (Ency) Lee, Ph.D; Namhyun Kim; Hwanjun Yoon, Ph.D.; Sukhwan Kim; Ahyeon Hwang
Samsung Biologics
PAO-09-24-CL-07
Sep 30, 2024
Biotech
Five Small Biotechs to Watch: October 2024
David Alvaro, Ph.D.
Pharma's Almanac
PR-09-24-NI-10
Sep 23, 2024
dbDNA
Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA
Jill Makin
Touchlight
PAO-08-24-CL-01
Aug 19, 2024
Lipid Nanoparticles
Feasibility Studies and cGMP Design Supporting Continuous Lipid Nanoparticle Manufacturing
Jim Ziogas
DIANT Pharma
PAO-05-24-CL-03
May 30, 2024
mRNA Innovations
Technology Advances Needed to Drive Future mRNA Growth
Hagen Richter, Ph.D.
PAO-04-24-CL-04
Apr 15, 2024
mRNA Manufacturing
Navigating mRNA Manufacturing with Flexibility and Innovation
Michael van der Horst, Ph.D.
PAO-04-24-CL-02
Apr 08, 2024
Nice Insight Reports
Biotech Funding Ups and Downs
April Stanley, MS MBA
Nice Insight
PAO-04-24-NI-01
Apr 02, 2024
pDNA Manufacturing
Overcoming pDNA Supply Challenges for mRNA Manufacturing
Mack Kuo, Ph.D.
PAO-04-24-CL-01
Apr 01, 2024
1 / 5
